Over the past few decades, Hamilton has grown into an international leader for applied health research. Recently, two Hamilton companies made significant moves that have accelerated the growth of their businesses.
Hamilton’s Fusion Pharmaceuticals Goes NASDAQ
Fusion Pharmaceuticals Inc., a Hamilton-based cancer-treatment company, is seeking to be listed on the Nasdaq exchange filing its registration statement with the U.S. Securities and Exchange Commission for an initial public offering of US$100-million worth of common shares. A great story of applied research and why Hamilton is the city “Where Innovation Goes to Work”.
Hamilton’s Empirica Therapeutics Grows
Empirica Therapeutics (founded by Dr. Sheila Singh, MD, PhD, Professor of Surgery and Biochemistry and chief pediatric neurosurgeon at McMaster Children’s Hospital, and Dr. Jason Moffat, PhD, Professor of Molecular Genetics at the University of Toronto and an expert in functional genomics and gene-editing platforms) was recently acquired by US Based Century Therapeutics. Empirca’s science is focused on brain tumour identification and treatment and the newly formed Century Therapeutics Canada will be headquartered in Hamilton.
